TickerFacts.

Intellia Therapeutics, Inc. (NTLA): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

116.32M
As of 2025-12-31
140.02M
As of 2026-06-30
+10.1%
3-year compound annual growth
+11.9%
5-year compound annual growth
2015-12-31: 2.56M2016-12-31: 36.02M2017-12-31: 42.38M2018-12-31: 45.22M2019-12-31: 50.20M2020-12-31: 66.23M2021-12-31: 74.49M2022-12-31: 87.10M2023-12-31: 93.00M2024-12-31: 102.03M2025-12-31: 116.32M116.32M
2015-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31116.32M+14.0%2026-02-26, Balance as of period end
2024-12-31102.03M+9.7%2026-02-26, Balance as of period end
2023-12-3193.00M+6.8%2025-02-27, Balance as of period end
2022-12-3187.10M+16.9%2024-02-22, Balance as of period end
2021-12-3174.49M+12.5%2023-02-23, Balance as of period end
2020-12-3166.23Mn/c2022-02-24, Balance as of period end
2019-12-3150.20M+11.0%2021-02-26, Balance as of period end
2018-12-3145.22M+6.7%2020-02-27, Balance as of period end
2017-12-3142.38M+17.7%2019-02-27, Balance as of period end
2016-12-3136.02Mn/m2018-03-14, Balance as of period end
2015-12-312.56Mn/a2017-03-14, Balance as of period end